---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-001987"
form_type: "8-K"
ticker: "VYGR"
cik: "0001640266"
company_name: "Voyager Therapeutics, Inc."
filed_at: "2024-02-28T23:59:59+00:00"
generated_at: "2026-06-05T08:57:52.854212+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Voyager Therapeutics reports Q4 net income $56.4M, pro-forma cash $431M, pipeline milestones

## Summary
- Q4 collaboration revenue $90.1M (vs -$1.6M YoY), net income $56.4M (vs loss $23.6M).
- FY 2023 collaboration revenue $250.0M (vs $40.9M), net income $132.3M (vs loss $46.4M).
- Pro-forma cash $431M after Novartis $100M and Jan 2024 $100M public offering; runway into 2027.
- Selected development candidates: SOD1 ALS gene therapy (IND mid-2025) and Friedreich's ataxia (triggered $5M milestone, clinic 2025).
- Novartis collaboration: $80M upfront + $20M equity, up to $1.2B milestones; VY-TAU01 IND expected H1 2024.

## SEC filing metadata
- accession: 0001558370-24-001987
- form_type: 8-K
- ticker: VYGR
- cik: 0001640266
- company_name: Voyager Therapeutics, Inc.
- filed_at: 2024-02-28T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1640266/000155837024001987/0001558370-24-001987-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1640266/000155837024001987/vygr-20240228x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-001987
- JSON: https://secwatch.observer/filing/0001558370-24-001987.json
- Plain text: https://secwatch.observer/filing/0001558370-24-001987.txt

## Key facts
- Earnings Releases
  Voyager Therapeutics, Inc. reported Q4 2023 results: revenue $90.1 million, net income $56.4 million.
  - Period: Q4 2023
  - Revenue: $90.1 million
  - Net income: $56.4 million
  - Result: reported results
  source text: Voyager had collaboration revenue of $90.1 million for the fourth quarter of 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1640266/000155837024001987/0001558370-24-001987-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.